Background Primary membranous nephropathy (MN) is an autoimmune kidney disease in
which immune complexes are deposited beneath the epithelium in the glomeruli. The …

The phospholipase A2 receptor 1 (PLA2R1) is the major target antigen in patients with
membranous nephropathy (MN), an antibody-mediated autoimmune glomerular disease …

The phospholipase A2 receptor (PLA2R1) is the major autoantigen in idiopathic
membranous nephropathy (MN). However, the pathogenic role of anti‐PLA2R1 …

Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

As recently as 2002, most cases of primary membranous nephropathy (MN), a relatively
common cause of nephrotic syndrome in adults, were considered idiopathic. We now …

Recent findings in idiopathic membranous nephropathy (MN) suggest that in most patients,
the disease is because of anti-phospholipase A 2 receptor (PLA 2 R1) autoantibodies. Our …

The major form of membranous nephropathy is characterized by autoantibodies to
phospholipase A2 receptor 1 (PLA2R1). The study by Tomas et al. describes the first animal …

The majority of cases of primary membranous nephropathy (MN) are associated with auto-
antibodies against the podocyte antigen M-type phospholipase A2 receptor (PLA2R). This …

Background Idiopathic membranous nephropathy, a common form of the nephrotic
syndrome, is an antibody-mediated autoimmune glomerular disease. Serologic diagnosis …

Background Most primary membranous nephropathy (MN) is mediated by anti-
phospholipase A2 receptor (PLA2R) antibodies. Recently, these antibodies have been …